About
InVivo Therapeutics Holdings Corp. is a medical device and biotechnology company based in Cambridge, Massachusetts. Founded around 2010, it focuses on developing and commercializing innovative treatments for spinal cord injuries (SCI). The company originated from collaborative research at the Massachusetts Institute of Technology and Harvard Medical School, aiming to create effective therapies that restore function after SCI. The flagship product, the Neuro-Spinal Scaffold, is a patent-pending implantable device designed to provide structural support and promote neurological recovery following acute SCI. InVivo is also developing Neuro-Scaffold Plus Stem Cells for chronic SCI, along with a range of bioengineered neural trails and other biomaterial-based therapies. The company operates clinical development programs for acute spinal cord injuries and preclinical programs for chronic injuries, positioning itself as a leader in the field of neurological repair. Its mission is to advance treatments that address the underlying causes of spinal cord damage rather than just the symptoms.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2005
-
Annual Revenue $697964000
-
Total Funding $50522576
Location
1 Hampshire St, Cambridge, Massachusetts, United States, 02139
